Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience
- PMID: 22806618
- PMCID: PMC3492528
- DOI: 10.1002/hep.25947
Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience
Abstract
Bacterial infections are an important cause of mortality in cirrhosis, but there is a paucity of multicenter studies. The aim was to define factors predisposing to infection-related mortality in hospitalized patients with cirrhosis. A prospective, cohort study of patients with cirrhosis with infections was performed at eight North American tertiary-care hepatology centers. Data were collected on admission vitals, disease severity (model for endstage liver disease [MELD] and sequential organ failure [SOFA] scores), first infection site, type (community-acquired, healthcare-associated [HCA] or nosocomial), and second infection occurrence during hospitalization. The outcome was mortality within 30 days. A multivariate logistic regression model predicting mortality was created. 207 patients (55 years, 60% men, MELD 20) were included. Most first infections were HCA (71%), then nosocomial (15%) and community-acquired (14%). Urinary tract infections (52%), spontaneous bacterial peritonitis (SBP, 23%) and spontaneous bacteremia (21%) formed the majority of the first infections. Second infections were seen in 50 (24%) patients and were largely preventable: respiratory, including aspiration (28%), urinary, including catheter-related (26%), fungal (14%), and Clostridium difficile (12%) infections. Forty-nine patients (23.6%) who died within 30 days had higher admission MELD (25 versus 18, P < 0.0001), lower serum albumin (2.4 g/dL versus 2.8 g/dL, P = 0.002), and second infections (49% versus 16%, P < 0.0001) but equivalent SOFA scores (9.2 versus 9.9, P = 0.86). The case fatality rate was highest for C. difficile (40%), respiratory (37.5%), and spontaneous bacteremia (37%), and lowest for SBP (17%) and urinary infections (15%). The model for mortality included admission MELD (odds ratio [OR]: 1.12), heart rate (OR: 1.03) albumin (OR: 0.5), and second infection (OR: 4.42) as significant variables.
Conclusion: Potentially preventable second infections are predictors of mortality independent of liver disease severity in this multicenter cirrhosis cohort.
Copyright © 2012 American Association for the Study of Liver Diseases.
Figures


Similar articles
-
Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures.Hepatology. 2014 Jul;60(1):250-6. doi: 10.1002/hep.27077. Epub 2014 May 29. Hepatology. 2014. PMID: 24677131 Free PMC article.
-
Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1256-1263. doi: 10.1097/MEG.0000000000001481. Eur J Gastroenterol Hepatol. 2019. PMID: 31498284
-
Infection in cirrhosis: A prospective study.Ann Hepatol. 2019 Nov-Dec;18(6):862-868. doi: 10.1016/j.aohep.2019.07.010. Epub 2019 Sep 5. Ann Hepatol. 2019. PMID: 31635968
-
Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management?World J Gastroenterol. 2014 Oct 21;20(39):14079-86. doi: 10.3748/wjg.v20.i39.14079. World J Gastroenterol. 2014. PMID: 25339797 Free PMC article. Review.
-
Factors determining the mortality in cirrhosis patients with invasive candidiasis: A systematic review and meta-analysis.Med Mycol. 2021 Dec 8;60(1):myab069. doi: 10.1093/mmy/myab069. Med Mycol. 2021. PMID: 34734272
Cited by
-
The Worsening Profile of Alcoholic Hepatitis in the United States.Alcohol Clin Exp Res. 2016 Jun;40(6):1295-303. doi: 10.1111/acer.13069. Epub 2016 May 5. Alcohol Clin Exp Res. 2016. PMID: 27147285 Free PMC article.
-
Unresolved issues in the prophylaxis of bacterial infections in patients with cirrhosis.World J Hepatol. 2018 Dec 27;10(12):892-897. doi: 10.4254/wjh.v10.i12.892. World J Hepatol. 2018. PMID: 30631393 Free PMC article.
-
A neutrophil-to-lymphocyte ratio-based prognostic model to predict mortality in patients with HBV-related acute-on-chronic liver failure.BMC Gastroenterol. 2021 Nov 10;21(1):422. doi: 10.1186/s12876-021-02007-w. BMC Gastroenterol. 2021. PMID: 34758747 Free PMC article.
-
Alterations in Skin Microbiomes of Patients With Cirrhosis.Clin Gastroenterol Hepatol. 2019 Nov;17(12):2581-2591.e15. doi: 10.1016/j.cgh.2019.03.028. Epub 2019 Mar 21. Clin Gastroenterol Hepatol. 2019. PMID: 30905718 Free PMC article.
-
Acute kidney injury in acute on chronic liver failure.Hepatol Int. 2016 Mar;10(2):245-57. doi: 10.1007/s12072-015-9652-y. Epub 2015 Oct 15. Hepatol Int. 2016. PMID: 26471272 Review.
References
-
- Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodes J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35:140–148. - PubMed
-
- Merli M, Lucidi C, Giannelli V, Giusto M, Riggio O, Falcone M, Ridola L, et al. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol. 2010;8:979–985. - PubMed
-
- Fernandez J, Acevedo J, Castro M, Garcia O, Rodriguez de Lope C, Roca D, Pavesi M, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study. Hepatology. 2011 - PubMed
-
- Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoli F, Boccia S, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis. 2001;33:41–48. - PubMed
-
- Arvaniti V, D'Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, Burroughs AK. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010;139:1246–1256. 1256, e1241–e1245. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical